The IRCCS San Raffaele Hospital and the Vita-Salute San Raffaele University announced the launch of a long-term partnership with the recently established Nicolelis Institute for Advanced Brain Studies of the Brazilian Alberto Santos Dumont Association for Research Support (AASDAP, www.aasdap.org.br) aimed at creating a state-of-the-art Neurotech Hub on their campus in the city of Milan. Resulting from a two-year planning process, that included the development of a comprehensive Master Plan, the San Raffaele Neurotech Hub will be the first initiative of this kind in Europe focused on deploying large-scale modern neurotechnologies and neurorehabilitation protocols, based on the employment of a novel and generic non-invasive brain-machine interface (nBMI) approach (Figure 1). This nBMI will serve as the foundation of multiple neurorehabilitation protocols and therapies targeting patients suffering from a variety of neurological disorders, such as spinal cord injury, Parkinson’s disease, stroke, multiple sclerosis, and chronic epilepsy.  

An electrode with films of iridium dioxide and niobium oxide on a titanium substrate removed molecules of the drug levofloxacin, considered an emerging pollutant. The study obtained excellent results in terms of degrading the drug in simulated and real water samples.

For three months, Brazilian researchers tracked 74 patients submitted to 12 sessions lasting 15 minutes each and observed remission of symptoms. The ancient Chinese practice had no side effects, according to an article on the study published in JAMA Network Open.

Researchers at the Federal University of São Carlos found that glitter’s metal coating reduced the amount of light penetrating water bodies and hence impaired photosynthesis by the Large-flowered waterweed Egeria densa. The problem may impact primary producer organisms at the bottom of the food chain, they warn.

The results of a study conducted by researchers at São Paulo State University (UNESP) could be highly positive for the future of the solar power sector.The method developed at UNESP involves the use of a class of materials called MXenes.

The solution developed by the firm, with FAPESP’s support, is currently being validated by UN’s International Atomic Energy Agency.

In animal tests conducted at São Paulo State University (UNESP), the strategy reduced spleen and liver parasite numbers by 99.9%.